Accelerate Development with Lannett CDMO
- Streamlined development of oral solid dose formulations
- Extensive expertise and high-volume manufacturing
- Commitment to quality and regulatory compliance
Our track record speaks volumes
- 17 approved product applications since 2019
- 96% average product yield rate
- Zero critical FDA Form 483 observations
Learn More About Partnering with Lannett.
https://www.lannettcdmo.com/
- Streamlined development of oral solid dose formulations
- Extensive expertise and high-volume manufacturing
- Commitment to quality and regulatory compliance
Our track record speaks volumes
- 17 approved product applications since 2019
- 96% average product yield rate
- Zero critical FDA Form 483 observations
Learn More About Partnering with Lannett.
https://www.lannettcdmo.com/
Accelerate Development with Lannett CDMO - Streamlined development of oral solid dose formulations - Extensive expertise and high-volume manufacturing - Commitment to quality and regulatory compliance Our track record speaks volumes - 17 approved product applications since 2019 - 96% average product yield rate - Zero critical FDA Form 483 observations Learn More About Partnering with Lannett. https://www.lannettcdmo.com/
0 Commentarii
0 Distribuiri
1 Views
0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek